{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:46:07Z","timestamp":1792759567716,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22207056"],"award-info":[{"award-number":["22207056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41565-024-01783-2","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T06:03:30Z","timestamp":1727330610000},"page":"156-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7310-7982","authenticated-orcid":false,"given":"Xianguang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingJing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-4844","authenticated-orcid":false,"given":"Kefeng","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-2373","authenticated-orcid":false,"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4965-7519","authenticated-orcid":false,"given":"Fei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjun","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8539-9062","authenticated-orcid":false,"given":"David Tai","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-9172","authenticated-orcid":false,"given":"Lianhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N Hilf","year":"2019","unstructured":"Hilf, N. et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565, 240\u2013245 (2019).","journal-title":"Nature"},{"key":"1783_CR2","doi-asserted-by":"crossref","first-page":"eabc2816","DOI":"10.1126\/scitranslmed.abc2816","volume":"13","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines. Sci. Transl. Med. 13, eabc2816 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1783_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","volume":"20","author":"A M\u00f6ller","year":"2020","unstructured":"M\u00f6ller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in cancer. Nat. Rev. Cancer 20, 697\u2013709 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu, R. et al. Extracellular vesicles in cancer-implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 15, 617\u2013638 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1783_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas, E. I. The roles of extracellular vesicles in the immune system. Nat. Rev. Immunol. 23, 236\u2013250 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1783_CR6","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"1783_CR7","doi-asserted-by":"crossref","first-page":"eabb6981","DOI":"10.1126\/scitranslmed.abb6981","volume":"13","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 13, eabb6981 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1783_CR8","doi-asserted-by":"crossref","first-page":"eaay7735","DOI":"10.1126\/sciadv.aay7735","volume":"6","author":"X Xi","year":"2020","unstructured":"Xi, X. et al. Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination. Sci. Adv. 6, eaay7735 (2020).","journal-title":"Sci. Adv."},{"key":"1783_CR9","volume":"11","author":"L Rao","year":"2020","unstructured":"Rao, L. et al. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat. Commun. 11, 4909 (2020).","journal-title":"Nat. Commun."},{"key":"1783_CR10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/1541-7786.MCR-20-0956","volume":"19","author":"A Shimizu","year":"2021","unstructured":"Shimizu, A. et al. Exosomal CD47 plays an essential role in immune evasion in ovarian cancer. Mol. Cancer Res. 19, 1583\u20131595 (2021).","journal-title":"Mol. Cancer Res."},{"key":"1783_CR11","doi-asserted-by":"crossref","first-page":"E2646","DOI":"10.1073\/pnas.1604268113","volume":"113","author":"JT Sockolosky","year":"2016","unstructured":"Sockolosky, J. T. et al. Durable antitumor responses to CD47 blockade require adaptive immune stimulation. Proc. Natl Acad. Sci. USA 113, E2646\u2013E2654 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1783_CR12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm.3965","volume":"21","author":"RH Vonderheide","year":"2015","unstructured":"Vonderheide, R. H. CD47 blockade as another immune checkpoint therapy for cancer. Nat. Med. 21, 1122\u20131123 (2015).","journal-title":"Nat. Med."},{"key":"1783_CR13","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1021\/bi00514a022","volume":"20","author":"J Wilschut","year":"1981","unstructured":"Wilschut, J., Duezguenes, N. & Papahadjopoulos, D. Calcium\/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the role of bilayer curvature. Biochemistry 20, 3126\u20133133 (1981).","journal-title":"Biochemistry"},{"key":"1783_CR14","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1021\/ac301899h","volume":"84","author":"L Zhu","year":"2012","unstructured":"Zhu, L. et al. In vitro selection of highly efficient G-quadruplex-based DNAzymes. Anal. Chem. 84, 8383\u20138390 (2012).","journal-title":"Anal. Chem."},{"key":"1783_CR15","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1021\/ac100940v","volume":"82","author":"DM Kong","year":"2010","unstructured":"Kong, D. M., Xu, J. & Shen, H. X. Positive effects of ATP on G-Quadruplex-hemin DNAzyme-mediated reactions. Anal. Chem. 82, 6148\u20136153 (2010).","journal-title":"Anal. Chem."},{"key":"1783_CR16","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1021\/jacs.3c02625","volume":"145","author":"SK Bhuyan","year":"2023","unstructured":"Bhuyan, S. K. et al. Directed evolution of a G-quadruplex peroxidase DNAzyme and application in proteomic DNAzyme-aptamer proximity labeling. J. Am. Chem. Soc. 145, 12726\u201312736 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"1783_CR17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02186-9","volume":"8","author":"F Veglia","year":"2017","unstructured":"Veglia, F. et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat. Commun. 8, 2122 (2017).","journal-title":"Nat. Commun."},{"key":"1783_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat. Rev. Cancer 21, 298\u2013312 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","volume":"19","author":"M Feng","year":"2019","unstructured":"Feng, M. et al. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat. Rev. Cancer 19, 568\u2013586 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1783_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-021-03815-z","volume":"148","author":"YC Chen","year":"2022","unstructured":"Chen, Y. C., Shi, W., Shi, J. J. & Lu, J. J. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective. J. Cancer Res. Clin. Oncol. 148, 1\u201314 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1783_CR21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41565-022-01245-7","volume":"17","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nat. Nanotech 17, 1332\u20131341 (2022).","journal-title":"Nat. Nanotech"},{"key":"1783_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biomaterials.2016.07.032","volume":"105","author":"AK Hauser","year":"2016","unstructured":"Hauser, A. K. et al. Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials 105, 127\u2013135 (2016).","journal-title":"Biomaterials"},{"key":"1783_CR23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.biomaterials.2015.02.068","volume":"52","author":"V Mulens-Arias","year":"2015","unstructured":"Mulens-Arias, V., Rojas, J. M., P\u00e9rez-Yag\u00fce, S., Morales, M. P. & Barber, D. F. Barber polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials 52, 494\u2013506 (2015).","journal-title":"Biomaterials"},{"key":"1783_CR24","doi-asserted-by":"crossref","first-page":"22132","DOI":"10.1038\/s41598-021-01374-4","volume":"11","author":"F Batool","year":"2021","unstructured":"Batool, F. et al. Biologically synthesized iron nanoparticles (FeNPs) from Phoenix dactylifera have anti-bacterial activities. Sci. Rep. 11, 22132\u201322140 (2021).","journal-title":"Sci. Rep."},{"key":"1783_CR25","doi-asserted-by":"crossref","first-page":"20008","DOI":"10.1002\/anie.202006649","volume":"59","author":"S Jiang","year":"2020","unstructured":"Jiang, S. et al. Synergistic anticancer therapy by ovalbumin encapsulation\u2010enabled tandem reactive oxygen species generation. Angew. Chem. Int. Ed. Engl. 59, 20008\u201320016 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1783_CR26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557\u2013569 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1783_CR27","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2008-01-134791","volume":"112","author":"AR Mantegazza","year":"2008","unstructured":"Mantegazza, A. R. et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712\u20134722 (2008).","journal-title":"Blood"},{"key":"1783_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2006.05.035","volume":"126","author":"A Savina","year":"2006","unstructured":"Savina, A. et al. NOX2 controls phagosomal pH to regulate antigen processing during cross presentation by dendritic cells. Cell 126, 205\u2013218 (2006).","journal-title":"Cell"},{"key":"1783_CR29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4049\/jimmunol.1601694","volume":"198","author":"Y Kitai","year":"2017","unstructured":"Kitai, Y. et al. DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J. Immunol. 198, 1649\u20131659 (2017).","journal-title":"J. Immunol."},{"key":"1783_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","volume":"3","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling tumor cell-derived microparticles as vaccine. Cancer Immunol. Res. 3, 196\u2013205 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"1783_CR31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s40425-019-0772-0","volume":"7","author":"E Voets","year":"2019","unstructured":"Voets, E. et al. Functional characterization of the selective pan-allele anti-SIRP\u03b1 antibody ADU-1805 that blocks the SIRP\u03b1-CD47 innate immune checkpoint. J. Immunother. Cancer 7, 340\u2013354 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1783_CR32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1200\/JCO.18.02018","volume":"37","author":"BI Sikic","year":"2019","unstructured":"Sikic, B. I. et al. First-in-human, first-in-class phase I trial of the anti-CD47 antibody hu5F9-G4 in patients with advanced cancers. J. Clin. Oncol. 37, 946\u2013953 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1783_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1783_CR34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat. Med. 27, 212\u2013224 (2021).","journal-title":"Nat. Med."},{"key":"1783_CR35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism in the tumor microenvironment. Cell. Metab. 30, 36\u201350 (2019).","journal-title":"Cell. Metab."},{"key":"1783_CR36","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1021\/jacs.8b10904","volume":"141","author":"Z Gu","year":"2019","unstructured":"Gu, Z. et al. Mechanism of iron oxide-induced macrophage activation:tThe impact of composition and the underlying signaling pathway. J. Am. Chem. Soc. 141, 6122\u20136126 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"1783_CR37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2013.75","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res. 23, 898\u2013914 (2013).","journal-title":"Cell Res."},{"key":"1783_CR38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41551-020-0583-0","volume":"4","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma. Nat. Biomed. Eng. 4, 743\u2013753 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1783_CR39","doi-asserted-by":"crossref","first-page":"eabe2749","DOI":"10.1126\/sciimmunol.abe2749","volume":"6","author":"C Bangert","year":"2021","unstructured":"Bangert, C. et al. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade. Sci. Immunol. 6, eabe2749 (2021).","journal-title":"Sci. Immunol."},{"key":"1783_CR40","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1172\/JCI45585","volume":"121","author":"N Woller","year":"2011","unstructured":"Woller, N. et al. Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. J. Clin. Invest. 121, 2570\u20132582 (2011).","journal-title":"J. Clin. Invest."},{"key":"1783_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41565-021-01032-w","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat. Nanotechnol. 17, 206\u2013216 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"1783_CR42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2003-0238OC","volume":"31","author":"MP Bard","year":"2004","unstructured":"Bard, M. P. et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 31, 114\u2013121 (2004).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1783_CR43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382\u2013386 (2018).","journal-title":"Nature"},{"key":"1783_CR44","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1002\/ange.201801815","volume":"130","author":"Y Xian","year":"2018","unstructured":"Xian, Y. et al. Controllable assembly of enzymes for multiplexed lab-on-a-Chip bioassays with a tunable detection range. Angew. Chem. Int. Ed. 130, 7625\u20137629 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1783_CR45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/accountsmr.1c00276","volume":"3","author":"F Tian","year":"2022","unstructured":"Tian, F., Chao, L., Deng, J. & Sun, J. Microfluidic separation, detection, and engineering of extracellular vesicles for cancer diagnostics and drug delivery. Acc. Mater. Res. 3, 498\u2013510 (2022).","journal-title":"Acc. Mater. Res."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01783-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01783-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:35:58Z","timestamp":1737480958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01783-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1038\/s41565-024-01783-2","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}